Patheon Softgels Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PATHEON SOFTGELS
PATHEON SOFTGELS has two approved drugs.
Summary for Patheon Softgels
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Patheon Softgels
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patheon Softgels | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 214463-001 | Jan 10, 2023 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Patheon Softgels | IBUPROFEN | ibuprofen | CAPSULE;ORAL | 217236-001 | Feb 13, 2024 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
